Skip to content

Hyperspectral imaging and hematorheological examination for evaluation of microcirculation in neonatology and pediatrics

Hyperspectral imaging and hematorheological examination for evaluation of microcirculation in neonatology and pediatrics - NeoPedHSI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037006
Enrollment
225
Registered
2025-06-11
Start date
2025-06-04
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

isolation of macro- and microcirculation, (tissue) hypoperfusion, formation of edema

Interventions

Group 1: healthy term newborns (>36+6 pregnancy weeks) Hyperspectral imaging of the thorax (= HSI: spectrum, tissue oxygenation (StO2), near infrared perfusion index (NIR), tissue hemoglobin index (TH

Sponsors

Universitätsklinikum Heidelberg, Klinik für Neonatologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 17 Years

Inclusion criteria

Inclusion criteria: consent of legal guardians

Exclusion criteria

Exclusion criteria: missing consent

Design outcomes

Primary

MeasureTime frame
There is a difference in microcirculation (perfusion, oxygenation and tissue water content) and rheology between newborns, preterms and older kids, which can be shown by hyperspectral imaging

Secondary

MeasureTime frame
Changes in microcirculation by therapeutic interventions (fluid boli, vasopressor therapy, transfusion) can be measured by hyperspectral imaging (fluid/vasopressor responsiveness). To predict the success of therapeutic interventions, AI-based models can be used by analysing microcirculatory changes the a basis of hyperspectral image data. HSI (supported by AI-based models) can be used to predict Sepsis in pediatric patients.

Countries

Germany

Contacts

Public ContactChristian Gille

Universitätsklinikum Heidelberg, Klinik für Neonatologie

Neonatologie.Kind@med.uni-heidelberg.de+49 6221 56-39882

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026